Core Insights - The Pennant Group is optimistic about business momentum and growth initiatives while emphasizing a cautious approach to integrating major acquisitions and navigating a changing competitive landscape [6] Acquisition and Integration - The integration of the newly acquired operations from UnitedHealth Group and Amedisys is structured into five waves, with the second wave currently being completed and the full transition expected to conclude by the end of October [7] - Management is taking a methodical approach to integration to reduce risk and retain strong teams, acknowledging that the current integration is more complex than previous acquisitions [1][4] - Early feedback from employees has been positive, with a strong commitment to the company's culture and clarity about the transition [8] Financial Guidance and Performance - The company’s guidance includes conservatism due to the scale and complexity of the recent transactions, with expectations for margin expansion in both Home Health and Hospice segments [2][12] - For 2026, the company anticipates an annualized margin close to 10.5% for the acquired business, with a long-term goal of reaching an 18% target margin [10][11] - The company expects an annualized EBITDA margin around 16% for Home Health and Hospice, and around 11% for Senior Living [12] Market Dynamics and Opportunities - The competitive landscape has shifted, with large players entering integration cycles, creating increased opportunities for Pennant [13] - The company has expanded its footprint into the Southeast and Northeast, enhancing its national profile and payer negotiations [14] - There are numerous attractive acquisition opportunities available, although the company is focusing on tuck-in deals due to the integration workload [15] Senior Living and Regulatory Environment - In Senior Living, occupancy has improved, with a current rate of around 81% and a goal of 85% [16] - The company expressed gratitude for a reduced home health rate adjustment, which alleviates some regulatory pressure [17] Strategic Focus - The company emphasizes local leadership and organic growth alongside acquisitions, with technology and AI investments seen as key strategic focuses for future value creation [18]

EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2026.  Brent Guerisoli, Chief Executive Officer, and Lynette Walbom, Chief Financial Officer will participate in a fireside chat on March 18, 2026 at 10:40 a.m. Eastern Time. A liv ...

Core Insights - The Pennant Group reported a strong performance in 2025, driven by acquisitions, same-store improvements, and leadership development, with a focus on five key areas: leadership development, clinical excellence, employee experience, margin improvement, and growth [1][4][7] Financial Performance - For the full year 2025, Pennant achieved revenue of $947.7 million, an increase of $252.5 million or 36.3% compared to the previous year [2][7] - Adjusted EBITDA rose to $72.5 million, up $19.2 million or 36%, while adjusted EBITDA prior to noncontrolling interests increased to $76.7 million, an improvement of $21.6 million or 39.2% [2][7] - The adjusted earnings per share (EPS) for 2025 was $1.18, exceeding the midpoint of the company's updated guidance of $1.16 [3][7] Growth and Acquisitions - The company made significant expansions in 2025, including the acquisition of Signature Healthcare at Home and over 50 locations from UnitedHealth/Amedisys, marking its largest acquisition to date [6][9] - Management anticipates continued growth in 2026, with guidance for revenue between $1.13 billion and $1.17 billion, adjusted EBITDA of $88.5 million to $94.1 million, and adjusted EPS of $1.26 to $1.36 [5][18] Segment Performance - In the home health and hospice segment, fourth-quarter revenue reached $233.3 million, up 64.3% year over year, with adjusted EBITDA of $33.7 million, up 58.2% [11] - The hospice quality composite score was reported at 97.5%, contributing to an all-time high average daily census of 5,060, up 46.9% year over year [12] - Senior living segment revenue increased to $215 million for the full year, up 22.3%, with fourth-quarter revenue rising 19.6% to $56.1 million [12] Balance Sheet and Cash Flow - The company expanded its credit facility with a $100 million term loan, bringing the total to $350 million, and reported net debt to adjusted EBITDA of 1.7x [14] - Operating cash flow was $21 million in the fourth quarter and $48.3 million year to date, with expectations for 2026 operating cash flow of $45 million to $55 million [15] Strategic Outlook - Management views healthcare as a local business and aims to position itself as a premier independent provider, leveraging its locally driven operating model [17] - The Southeast footprint, supported by a new Nashville service center, is expected to become a strength, with a focus on integration and optimization in 2026 [20]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [8] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% [8] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [7] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year [14] - Adjusted EBITDA for the home health segment in Q4 was $33.7 million, up $12.4 million, or 58.2% [14] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% [17] Market Data and Key Metrics Changes - The average daily census in the hospice segment grew to 5,060, a 46.9% increase over the prior year quarter [16] - Same-store Medicare admissions in home health grew by 8.2%, with a 3.7% increase in Medicare revenue per episode [15] - All-store occupancy in the senior living segment rose to 80.6%, with same-store occupancy increasing to 82.1% [18] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [10] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [9] - The company plans to continue expanding its senior living business, with significant growth potential identified [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance for 2026 in the range of $1.13 billion to $1.17 billion, reflecting a 22.4% increase at the midpoint [12] - Management highlighted the importance of local leadership in driving growth and maintaining strong clinical outcomes [59] Other Important Information - The company completed two senior living acquisitions in Q4, reinforcing its strategic commitment to expanding high-quality senior care [21][22] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [24] Q&A Session Summary Question: Is the guidance conservative due to the Amedisys/LHCG integration? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition [32] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners [34] Question: What are the expectations for the Amedisys UNH asset ramp-up compared to Signature? - Management noted similarities in leadership quality and operational readiness, expressing confidence in the transition process [41] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026 [53] Question: What is the competitive backdrop in the hospice segment? - Management highlighted a normalization in growth trends and emphasized the opportunity presented by the aging population [80]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [8] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [8] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [7][8] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [14] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [17] - Q4 senior living segment revenue was $56.1 million, an increase of $9.2 million, or 19.6% year-over-year [17] Market Data and Key Metrics Changes - The average daily census in hospice grew to 5,060, a 46.9% increase over the prior year quarter [16] - Same-store Medicare admissions in home health grew by 8.2%, with a 3.7% increase in Medicare revenue per episode [15] - All-store occupancy in senior living rose by 200 basis points to 80.6%, with same-store occupancy increasing by 250 basis points to 82.1% [18] Company Strategy and Development Direction - The company aims to optimize performance and drive operational excellence while remaining open to selective acquisitions [10] - Focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [9] - The company plans to continue expanding its senior living business, capitalizing on the upward trajectory of occupancy and revenue [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [12] - Management highlighted the importance of local leadership and community engagement in driving growth and clinical outcomes [59] Other Important Information - The company completed the acquisition of Signature Healthcare at Home and over 50 locations from UnitedHealth and Amedisys, enhancing its operational reach [8][9] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well below the covenant limit [24] Q&A Session Summary Question: Is the guidance conservative due to the integration of AMED LHCG? - Management confirmed that the guidance reflects expected initial noise during the transition of operations [32] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners [34] Question: What are the expectations for the ramp-up of Amedisys UNH assets? - Management noted similarities with previous acquisitions and expressed confidence in local leaders and teams to facilitate a smooth transition [41][42] Question: What is the outlook for same-store revenue growth in home health and hospice? - Management indicated a projected 7% increase in same-store home health and hospice revenue for 2026 [53] Question: What is the competitive backdrop in the hospice segment? - Management highlighted a normalization in growth trends and the opportunity presented by the aging population [80]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [6] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [6] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [5][6] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [12] - Fourth quarter admissions surged 81.3%, with Medicare admissions growing 87.5% year-over-year [12] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [16] Market Data and Key Metrics Changes - The average daily census in hospice care grew to 5,060, a 46.9% increase over the prior year quarter [15] - Same-store Medicare admissions in home health grew 8.2%, with a 3.7% increase in Medicare revenue per episode [13] - All store occupancy in senior living rose 200 basis points to 80.6%, with same-store occupancy ending the year at 82.1% [17] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [9] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [8] - The company aims to continue the upward trajectory of its senior living business, with significant growth potential ahead [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [11] - Management highlighted the importance of local leadership in responding to community needs and driving organic growth [57] Other Important Information - The company completed significant acquisitions, including the purchase of over 50 locations from UnitedHealth and Amedisys, enhancing its reach in the Southeast [8] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [23] - The company generated $21 million of cash flows from operations in Q4, bringing the year-to-date total to $48.3 million [23] Q&A Session Summary Question: Is the guidance conservative due to the integration of Amedisys and UnitedHealth? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition of operations [30] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners to achieve exceptional outcomes [32] Question: How does the Amedisys and UnitedHealth asset ramp-up compare to Signature? - Management noted similarities in leadership quality and operational strengths, expressing confidence in the transition process based on past experiences [39] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026, despite anticipated rate decreases [51] Question: What is the competitive landscape in the hospice segment? - Management highlighted a normalization in growth rates post-pandemic, with strong organic growth driven by local community needs [78]

Core Insights - The Pennant Group, Inc. reported a revenue of $289.32 million for the quarter ended December 2025, marking a year-over-year increase of 53.2% and an EPS of $0.34 compared to $0.24 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $273.04 million by 5.97%, while the EPS also surpassed the consensus estimate of $0.31 by 8.52% [1] Revenue Breakdown - Home health services revenue reached $116.43 million, exceeding the estimated $112.9 million, reflecting a year-over-year increase of 74.4% [4] - Hospice services generated $97.06 million, surpassing the estimated $92.42 million, with a year-over-year growth of 53.1% [4] - Senior living services reported revenue of $56.05 million, slightly below the estimated $57.06 million, but still showing a year-over-year increase of 19.6% [4] - Total revenue from home health and hospice services was $233.27 million, exceeding the average estimate of $220.6 million, representing a year-over-year change of 64.3% [4] - Home care and other services generated $19.78 million, surpassing the estimated $15.28 million, with a year-over-year increase of 66.7% [4] Stock Performance - The shares of The Pennant Group have returned +20.4% over the past month, significantly outperforming the Zacks S&P 500 composite, which changed by +0.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Revenue Growth and Market Trends - Home health and hospice services revenue grew by 336.3% from 2016 to 2025, with a compounded annual growth rate (CAGR) of 15.9%[39] - The home health market is projected to grow at a CAGR of 8.0% from 2024 to 2030, and the hospice industry is expected to grow at a CAGR of 8.1% during the same period[47] - The senior living market is anticipated to expand at a CAGR of 4.2% between 2024 to 2030[47] Company Operations and Growth Strategy - As of December 31, 2025, the company operated 172 home health and hospice agencies, a 341.0% increase since 2016[43] - The company provided senior living services in 63 communities with 4,428 total available units as of December 31, 2025[32] - The company aims to leverage its operational capabilities to expand partnerships and improve clinical outcomes through data analytics[37] - The disciplined acquisition strategy has been integral to the company's past success and future growth plans, focusing on strategic and underperforming operations[35] - The company plans to continue driving organic growth and acquiring additional operations in existing and new markets in a disciplined manner[38] - The company operated 172 home health and hospice agencies and 63 senior living communities across 16 states as of December 31, 2025[75] Revenue Sources and Payor Mix - Revenue from Medicare accounted for 48.4% of total revenue in 2025, while Medicaid contributed 13.1%[59] - Approximately 62.5%, 64.7%, and 66.9% of home health and hospice segment revenue was generated from Medicare in 2025, 2024, and 2023, respectively[31] - The blended payor mix as of December 31, 2025, was 48.4% Medicare, 13.1% Medicaid, 15.0% managed care, and 23.5% private pay and other sources[75] - Home health services generated 77.3% of total revenue, while senior living services accounted for 22.7% for the year ended December 31, 2025[75] - The company’s senior living services revenue is primarily derived from private pay residents, with Medicaid potentially supplementing payments[118] Quality and Compliance - The average CMS five-star quality rating for home health agencies was 4.2 out of 5, significantly higher than the industry average of 3.0 stars[74] - Home health agencies achieved an average of 4.2 out of 5 stars in the CMS Quality of Patient Care Star Rating, compared to the industry average of 3.0 stars[93] - Home health agencies must submit quality reporting data through OASIS assessments within 30 days, or face a 2% reduction in annual payment updates[91] - As of October 1, 2023, hospice agencies that fail to submit required CAHPS survey data incur a 4% reduction in their annual base rate payment update[92] - Hospice agencies that do not meet quality reporting requirements face a 4% reduction in the annual market basket update for the next fiscal year[104] Financial Impacts and Regulatory Environment - The HH Payment Final Rule for 2026 resulted in a net payment update percentage of -1.3%, leading to an estimated decrease of $220 million in payments across all home health providers compared to fiscal year 2025[84] - The Hospice Payment Final Rule for 2026 included a payment update percentage of 2.6%, resulting in an estimated increase of $750 million in payments across all hospice providers compared to fiscal year 2025[85] - Approximately 68.3% of total expenses were payroll-related for the year ended December 31, 2025[78] - A 1.0% change in interest rates would result in an annual interest expense change of approximately $1.8 million based on the company's long-term debt as of December 31, 2025[272] - The company has a borrowing capacity of $250.0 million under the Amended Credit Agreement with a syndicate of banks[272] Competition and Market Challenges - The company faces increased competition from local and national providers, which may limit its ability to attract and retain patients and residents[67] - Home health agencies in certain states must obtain Certificates of Need (CON) for expansion, impacting market entry and service changes[105] Regulatory Compliance and Reporting - The company is subject to extensive regulatory inspections, with unannounced surveys occurring at least annually at independent operating subsidiaries[112] - The company must comply with HIPAA regulations, which impose significant costs for maintaining patient health information confidentiality[115] - The company faces potential sanctions from CMS or state regulators if operations with poor regulatory histories are acquired[114] - The company is required to file reports with the SEC, including annual reports on Form 10-K and quarterly reports on Form 10-Q[121] - The company is subject to federal and state antitrust laws, with increasing enforcement activity noted in the healthcare sector[117] - The company must maintain compliance with various environmental laws and regulations affecting its senior living operations[119] - Failure to report standardized assessment data under the IMPACT Act may lead to a 2% reduction in market basket prices for post-acute care providers[103] Employee and Workforce Information - The company employs approximately 9,700 employees across its independent operating subsidiaries and Service Center as of December 31, 2025[76]

Revenue Growth - For the full year 2025, total revenue was $947.7 million, an increase of $252.5 million or 36.3% year-over-year, and for Q4, revenue was $289.3 million, up $100.4 million or 53.2% year-over-year[2] - Home Health and Hospice Services segment revenue for the full year was $732.7 million, an increase of $213.2 million or 41.0% year-over-year, and for Q4, it was $233.3 million, up $91.3 million or 64.3% year-over-year[2] - Senior Living Services segment revenue for the full year was $215.0 million, an increase of $39.2 million or 22.3% year-over-year, and for Q4, it was $56.1 million, up $9.2 million or 19.6% year-over-year[4] - Home health and hospice revenue increased to $732.727 million in 2025, up 41.0% from $519.484 million in 2024[24] - Total revenue for the three months ended December 31, 2025, was $289.323 million, a 53.0% increase from $188.892 million in 2024[29] Net Income and Earnings - Full year net income was $29.6 million, an increase of $7.0 million or 31.1% year-over-year, and for Q4, net income was $8.6 million, up $2.9 million or 50.0% year-over-year[2] - Net income for the year ended December 31, 2025, was $33,764,000, a 38.8% increase compared to $24,339,000 in 2024[18] - The company reported a net income attributable to The Pennant Group, Inc. of $29,578 million for the year ended December 31, 2025, compared to $22,559 million in 2024, reflecting a 31.0% increase[38] Operational Performance - Adjusted diluted earnings per share for the full year was $1.18, and for Q4, it was $0.34, reflecting strong operational performance[1] - Total home health admissions for the full year were 86,076, an increase of 26,335 or 44.1% year-over-year, and for Q4, admissions were 28,941, up 12,982 or 81.3% year-over-year[2] - Hospice average daily census for the full year was 4,204, an increase of 936 or 28.6% year-over-year, and for Q4, it was 5,060, up 1,615 or 46.9% year-over-year[4] - Total home health admissions increased by 81.3% to 28,941 in Q4 2025 compared to 15,959 in Q4 2024[23] Future Projections - The company anticipates 2026 total revenue to be between $1,133.6 million and $1,171.8 million, with adjusted earnings per diluted share expected to be between $1.26 and $1.36[4][5] - Adjusted EBITDA for 2026 is anticipated to be between $88.5 million and $94.1 million, reflecting management's expectations based on 2025 performance[5][6] Financial Position - Total current assets increased to $167,406,000 in 2025 from $122,856,000 in 2024, reflecting a 36.2% growth[16] - Total liabilities rose to $593,927,000 in 2025, up from $367,556,000 in 2024, indicating a 61.6% increase[16] - Total assets reached $968,179,000 in 2025, up from $679,521,000 in 2024, marking a 42.5% growth[16] - Cash at the end of the period decreased to $17,024,000 in 2025 from $24,246,000 in 2024, a decline of 29.9%[18] Medicare Revenue - Medicare revenue for the year ended December 31, 2025, was $458.299 million, accounting for 48.4% of total revenue, compared to 48.3% in 2024[30] - Average Medicare revenue per 60-day completed episode for home health services slightly increased by 0.8% to $3,755 in Q4 2025[23] - Average Medicare revenue per 60-day completed episode increased to $3,755 in 2025, up 3.5% from $3,628 in 2024[24] Adjusted Metrics - Consolidated Adjusted EBITDA for the year ended December 31, 2025, reached $72,466 million, compared to $53,286 million in 2024, indicating a 36.1% growth[38] - Segment Adjusted EBITDAR from Operations for Home Health and Hospice Services for the three months ended December 31, 2025, was $36,804 million, up from $23,221 million in 2024, a 58.5% increase[42] - Segment Adjusted EBITDA from Operations for Home Health and Hospice in Q4 2025 was $33,712 million, up from $21,304 million in Q4 2024, marking a 58% increase[45] Expenses and Costs - Unallocated corporate expenses increased to $60,455 million in 2025 from $43,587 million in 2024, a rise of 39%[43] - Share-based compensation expense for the year 2025 was $9,036 million, compared to $8,242 million in 2024, an increase of 10%[43] - Acquisition-related costs for the year 2025 totaled $6,587 million, significantly higher than $1,278 million in 2024, reflecting a 417% increase[43] - Rent—cost of services for the year 2025 was $48,700 million, compared to $43,029 million in 2024, a rise of 13%[43] Transition Services - The company incurred $3,001 million in fees under the Transition Services Agreement with UnitedHealth for the year ended December 31, 2025[39] - Transition services costs incurred under the agreement with UnitedHealth amounted to $3,001 million for the year ended December 31, 2025[44]

Core Insights - The Pennant Group, Inc. reported strong financial results for the year 2025, with significant increases in revenue, net income, and adjusted earnings per share, indicating robust growth in its home health, hospice, and senior living services [1][2][4]. Financial Performance - Total revenue for 2025 was $947.7 million, a 36.3% increase from the previous year, with fourth-quarter revenue reaching $289.3 million, up 53.2% year-over-year [2][22]. - Net income for the full year was $29.6 million, a 31.1% increase, while fourth-quarter net income was $8.6 million, up 50.0% compared to the prior year quarter [2][3]. - Adjusted net income for 2025 was $41.6 million, reflecting a 38.9% increase, with fourth-quarter adjusted net income at $12.2 million, up 43.1% year-over-year [2][32]. Segment Performance - Home Health and Hospice Services segment revenue for 2025 was $732.7 million, a 41.0% increase, with fourth-quarter revenue at $233.3 million, up 64.3% [2][22]. - Senior Living Services segment revenue for 2025 was $215.0 million, a 22.3% increase, with fourth-quarter revenue at $56.1 million, up 19.6% [2][27]. Operational Metrics - Total home health admissions for 2025 were 86,076, a 44.1% increase, with fourth-quarter admissions at 28,941, up 81.3% [2][24]. - Hospice average daily census for 2025 was 4,204, a 28.6% increase, with fourth-quarter census at 5,060, up 46.9% [2][27]. - Senior living average occupancy for the fourth quarter was 80.6%, an increase of 200 basis points year-over-year, with average monthly revenue per occupied room at $5,238, up 5.6% [2][27]. Guidance for 2026 - The company anticipates total revenue for 2026 to be between $1,133.6 million and $1,171.8 million, with adjusted earnings per diluted share expected to be between $1.26 and $1.36 [5][6]. - Adjusted EBITDA for 2026 is projected to be between $88.5 million and $94.1 million [5][6]. Management Commentary - The CEO highlighted 2025 as a year of record-breaking performance and strategic growth, emphasizing the importance of operational excellence and successful integration of new operations [4][6]. - The COO noted the focus on maintaining momentum and delivering strong results across all key growth metrics, indicating confidence in continued success in 2026 [4][6].